166 related articles for article (PubMed ID: 8926079)
1. Expression of sialyltransferase is not required for interaction of Neisseria gonorrhoeae with human epithelial cells and human neutrophils.
McGee DJ; Chen GC; Rest RF
Infect Immun; 1996 Oct; 64(10):4129-36. PubMed ID: 8926079
[TBL] [Abstract][Full Text] [Related]
2. Regulation of gonococcal sialyltransferase, lipooligosaccharide, and serum resistance by glucose, pyruvate, and lactate.
McGee DJ; Rest RF
Infect Immun; 1996 Nov; 64(11):4630-7. PubMed ID: 8890217
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of a sialyltransferase-deficient mutant of Neisseria gonorrhoeae.
Gill MJ; McQuillen DP; van Putten JP; Wetzler LM; Bramley J; Crooke H; Parsons NJ; Cole JA; Smith H
Infect Immun; 1996 Aug; 64(8):3374-8. PubMed ID: 8757878
[TBL] [Abstract][Full Text] [Related]
4. Growth of Neisseria gonorrhoeae in CMP-N-acetylneuraminic acid inhibits nonopsonic (opacity-associated outer membrane protein-mediated) interactions with human neutrophils.
Rest RF; Frangipane JV
Infect Immun; 1992 Mar; 60(3):989-97. PubMed ID: 1541573
[TBL] [Abstract][Full Text] [Related]
5. Anaerobic growth and cytidine 5'-monophospho-N-acetylneuraminic acid act synergistically to induce high-level serum resistance in Neisseria gonorrhoeae.
Frangipane JV; Rest RF
Infect Immun; 1993 May; 61(5):1657-66. PubMed ID: 8478054
[TBL] [Abstract][Full Text] [Related]
6. A serum-sensitive, sialyltransferase-deficient mutant of Neisseria gonorrhoeae defective in conversion to serum resistance by CMP-NANA or blood cell extracts.
Bramley J; Demarco de Hormaeche R; Constantinidou C; Nassif X; Parsons N; Jones P; Smith H; Cole J
Microb Pathog; 1995 Mar; 18(3):187-95. PubMed ID: 7565013
[TBL] [Abstract][Full Text] [Related]
7. Interaction of pathogenic Neisseria with host defenses. What happens in vivo?
Rest RF; Liu J; Talukdar R; Frangipane JV; Simon D
Ann N Y Acad Sci; 1994 Aug; 730():182-96. PubMed ID: 8080170
[TBL] [Abstract][Full Text] [Related]
8. α-2,3-sialyltransferase expression level impacts the kinetics of lipooligosaccharide sialylation, complement resistance, and the ability of Neisseria gonorrhoeae to colonize the murine genital tract.
Lewis LA; Gulati S; Burrowes E; Zheng B; Ram S; Rice PA
mBio; 2015 Feb; 6(1):. PubMed ID: 25650401
[TBL] [Abstract][Full Text] [Related]
9. The Neisseria lipooligosaccharide-specific alpha-2,3-sialyltransferase is a surface-exposed outer membrane protein.
Shell DM; Chiles L; Judd RC; Seal S; Rest RF
Infect Immun; 2002 Jul; 70(7):3744-51. PubMed ID: 12065517
[TBL] [Abstract][Full Text] [Related]
10. Differential expression and transcriptional analysis of the alpha-2,3-sialyltransferase gene in pathogenic Neisseria spp.
Packiam M; Shell DM; Liu SV; Liu YB; McGee DJ; Srivastava R; Seal S; Rest RF
Infect Immun; 2006 May; 74(5):2637-50. PubMed ID: 16622200
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a sialyltransferase-deficient mutant of Neisseria gonorrhoeae strain F62: instability of transposon Tn1545 delta3 in gonococci and evidence that multiple genetic loci are essential for lipooligosaccharide sialylation.
Crooke H; Griffiss JM; John CM; Lissenden S; Bramley J; Regan T; Smith H; Cole J
Microb Pathog; 1998 Nov; 25(5):237-52. PubMed ID: 9878453
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of conversion of Neisseria gonorrhoeae to resistance to complement by cytidine 5'-monophospho-N-acetyl neuraminic acid.
Emond JP; Dublanchet A; Goldner M
Antonie Van Leeuwenhoek; 1995; 67(3):281-8. PubMed ID: 7778896
[TBL] [Abstract][Full Text] [Related]
13.
Cardenas AJ; Thomas KS; Broden MW; Ferraro NJ; Pires MM; John CM; Jarvis GA; Criss AK
mBio; 2024 May; 15(5):e0011924. PubMed ID: 38587424
[TBL] [Abstract][Full Text] [Related]
14. Detection and some properties of the sialyltransferase implicated in the sialylation of lipopolysaccharide of Neisseria gonorrhoeae.
Mandrell RE; Smith H; Jarvis GA; Griffiss JM; Cole JA
Microb Pathog; 1993 Apr; 14(4):307-13. PubMed ID: 8326854
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo modification of Neisseria gonorrhoeae lipooligosaccharide epitope structure by sialylation.
Mandrell RE; Lesse AJ; Sugai JV; Shero M; Griffiss JM; Cole JA; Parsons NJ; Smith H; Morse SA; Apicella MA
J Exp Med; 1990 May; 171(5):1649-64. PubMed ID: 1692081
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the lipopolysaccharide-specific sialyltransferase activity of gonococci by the growth state of the bacteria, but not by carbon source, catabolite repression or oxygen supply.
Regan T; Watts A; Smith H; Cole J
Antonie Van Leeuwenhoek; 1999 May; 75(4):369-79. PubMed ID: 10510725
[TBL] [Abstract][Full Text] [Related]
17. Enhanced factor H binding to sialylated Gonococci is restricted to the sialylated lacto-N-neotetraose lipooligosaccharide species: implications for serum resistance and evidence for a bifunctional lipooligosaccharide sialyltransferase in Gonococci.
Gulati S; Cox A; Lewis LA; Michael FS; Li J; Boden R; Ram S; Rice PA
Infect Immun; 2005 Nov; 73(11):7390-7. PubMed ID: 16239538
[TBL] [Abstract][Full Text] [Related]
18. A high Mr factor in human blood which confers serum resistance on gonococci: some properties and synergism with CMP-NANA.
Constantinidou C; Beadle D; Zhou XH; Parsons NJ; Sammons CC; Cole JA; Smith H
Microb Pathog; 1992 Jun; 12(6):421-32. PubMed ID: 1522797
[TBL] [Abstract][Full Text] [Related]
19. Lactate enhancement of sialylation of gonococcal lipopolysaccharide and of induction of serum resistance by CMP-NANA is not due to direct activation of the sialyltransferase: metabolic events are involved.
Parsons NJ; Emond JP; Goldner M; Bramley J; Crooke H; Cole JA; Smith H
Microb Pathog; 1996 Sep; 21(3):193-204. PubMed ID: 8878016
[TBL] [Abstract][Full Text] [Related]
20.
Cardenas AJ; Thomas KS; Broden MW; Ferraro NJ; John CM; Pires MM; Jarvis GA; Criss AK
bioRxiv; 2024 Jan; ():. PubMed ID: 38293026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
